Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanako Shimizu

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Death Studies|February 18, 2020
Risk factors of severe prolonged grief disorder among individuals experiencing late-life bereavement in Japan: A qualitative studyKanako Shimizu
Critical Reviews in Oncogenesis|February 29, 2024
NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer TreatmentShin-Ichiro Fujii, Kanako Shimizu
Frontiers in Immunology|August 22, 2017
Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic CellsShin-Ichiro Fujii, Kanako Shimizu
Trends in Immunology|November 3, 2019
Immune Networks and Therapeutic Targeting of iNKT Cells in CancerShin-Ichiro Fujii, Kanako Shimizu
Oncoimmunology|June 5, 2013
Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune responseShin-Ichiro Fujii, Kanako Shimizu
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunityKanako Shimizu, Shin-ichiro Fujii
European Journal of Immunology|January 31, 2009
DC therapy induces long-term NK reactivity to tumors via host DCKanako Shimizu, Shin-ichiro Fujii
International Journal of Molecular Sciences|March 10, 2022
Identification of Neoantigens in Cancer Cells as Targets for ImmunotherapyMasahiro Okada, Kanako Shimizu, Shin-Ichiro Fujii
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2011
Prolonged antitumor NK cell reactivity elicited by CXCL10-expressing dendritic cells licensed by CD40L+ CD4+ memory T cellsKanako Shimizu, Miki Asakura, Shin-ichiro Fujii
Blood|January 24, 2009
Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunityShin-ichiro Fujii, Akira Goto, Kanako Shimizu
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Death Studies|February 18, 2020
Risk factors of severe prolonged grief disorder among individuals experiencing late-life bereavement in Japan: A qualitative studyKanako Shimizu
Critical Reviews in Oncogenesis|February 29, 2024
NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer TreatmentShin-Ichiro Fujii, Kanako Shimizu
Frontiers in Immunology|August 22, 2017
Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic CellsShin-Ichiro Fujii, Kanako Shimizu
Trends in Immunology|November 3, 2019
Immune Networks and Therapeutic Targeting of iNKT Cells in CancerShin-Ichiro Fujii, Kanako Shimizu
Oncoimmunology|June 5, 2013
Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune responseShin-Ichiro Fujii, Kanako Shimizu
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunityKanako Shimizu, Shin-ichiro Fujii
European Journal of Immunology|January 31, 2009
DC therapy induces long-term NK reactivity to tumors via host DCKanako Shimizu, Shin-ichiro Fujii
International Journal of Molecular Sciences|March 10, 2022
Identification of Neoantigens in Cancer Cells as Targets for ImmunotherapyMasahiro Okada, Kanako Shimizu, Shin-Ichiro Fujii
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2011
Prolonged antitumor NK cell reactivity elicited by CXCL10-expressing dendritic cells licensed by CD40L+ CD4+ memory T cellsKanako Shimizu, Miki Asakura, Shin-ichiro Fujii
Blood|January 24, 2009
Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunityShin-ichiro Fujii, Akira Goto, Kanako Shimizu
Pageof 8